114 related articles for article (PubMed ID: 25367137)
1. Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancer.
Mo ML; Ma J; Chen Z; Wei B; Li H; Zhou Y; Shi H; Tolani B; Jin JQ; Tseng HH; Shen D; Zhan Y; Li J; Jablons DM; Zhang RQ; Guo Y; He B; Zhou HM
J Cancer Res Clin Oncol; 2015 May; 141(5):901-8. PubMed ID: 25367137
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.
Sato T; Soejima K; Arai E; Hamamoto J; Yasuda H; Arai D; Ishioka K; Ohgino K; Naoki K; Kohno T; Tsuta K; Watanabe S; Kanai Y; Betsuyaku T
Oncol Rep; 2015 Sep; 34(3):1137-45. PubMed ID: 26134684
[TBL] [Abstract][Full Text] [Related]
3. Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I non-small cell lung cancer.
Harada H; Miyamoto K; Yamashita Y; Nakano K; Taniyama K; Miyata Y; Ohdan H; Okada M
Cancer; 2013 Feb; 119(4):792-8. PubMed ID: 23335114
[TBL] [Abstract][Full Text] [Related]
4. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.
Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis.
Suzuki M; Mohamed S; Nakajima T; Kubo R; Tian L; Fujiwara T; Suzuki H; Nagato K; Chiyo M; Motohashi S; Yasufuku K; Iyoda A; Yoshida S; Sekine Y; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I; Fujisawa T
Int J Oncol; 2008 Jul; 33(1):113-9. PubMed ID: 18575756
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC.
Grimminger PP; Maus MK; Schneider PM; Metzger R; Hölscher AH; Sugita H; Danenberg PV; Alakus H; Brabender J
Lung Cancer; 2012 Oct; 78(1):87-91. PubMed ID: 22884253
[TBL] [Abstract][Full Text] [Related]
9. Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer.
Harada H; Miyamoto K; Yamashita Y; Taniyama K; Mihara K; Nishimura M; Okada M
Cancer Med; 2015 Oct; 4(10):1536-46. PubMed ID: 26276761
[TBL] [Abstract][Full Text] [Related]
10. RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer.
Choi N; Son DS; Song I; Lee HS; Lim YS; Song MS; Lim DS; Lee J; Kim H; Kim J
Int J Cancer; 2005 Jul; 115(4):575-81. PubMed ID: 15700308
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of HMGB-1 and TGF-β Level in Serum and BALF of Advanced Non-Small Cell Lung Cancer.
Jakubowska K; Naumnik W; Niklińska W; Chyczewska E
Adv Exp Med Biol; 2015; 852():49-58. PubMed ID: 25753556
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation of
Guo Y; Zhang R; Shen S; Wei Y; Salama SM; Fleischer T; Bjaanæs MM; Karlsson A; Planck M; Su L; Zhu Z; Staaf J; Helland Å; Esteller M; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1527-1535. PubMed ID: 30185536
[TBL] [Abstract][Full Text] [Related]
13. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.
Carvalho RH; Hou J; Haberle V; Aerts J; Grosveld F; Lenhard B; Philipsen S
J Thorac Oncol; 2013 May; 8(5):562-73. PubMed ID: 23524404
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of BRMS1 correlates with smoking history and poor survival in non-small cell lung cancer patients.
Yang J; Shen Y; Liu B; Tong Y
Lung Cancer; 2011 Nov; 74(2):305-9. PubMed ID: 21726917
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
16. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
17. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
18. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
19. Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer.
Chen Y; Min L; Zhang X; Hu S; Wang B; Liu W; Wang R; Gu X; Shen W; Lv H; Zou J; Chen Y; Xu X; Chen L
Oncol Rep; 2013 Oct; 30(4):1832-40. PubMed ID: 23843100
[TBL] [Abstract][Full Text] [Related]
20. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
